Literature DB >> 25944473

Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson's Disease.

Musthafa Mohamed Essa1, Selvaraju Subash, Chinnasamy Dhanalakshmi, Thamilarasan Manivasagam, Samir Al-Adawi, Gilles J Guillemin, Arokiasamy Justin Thenmozhi.   

Abstract

Numerous studies indicating that natural plant sources and their active phytochemicals offer protection to the pathological processes related to the development of neurogenerative diseases including Parkinson's disease (PD). In the present study, the neuro protective efficacy of dietary supplementation of walnut (6 %) for 28 days was examined in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (i.p., 20 mg/kg body weight/day) for last four consecutive days. MPTP injection diminished the levels of GSH, dopamine and metabolites along with decreased activities of GPx and mitochondrial complex I. Further, the levels of TBARS and enzymatic antioxidants such as SOD and catalase, MAO-B activities were enhanced by MPTP treatment. Behavioral deficits and lowered TH expression are also proved MPTP induced neurotoxicity. Dietary supplementation of walnut attenuated MPTP-induced impairment in PD mice might be by its MAO-B inhibitory, antioxidant and mitochondrial protective actions. To find out the exact mechanism of action walnut on PD mice warrants further extensive studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25944473     DOI: 10.1007/s11064-015-1593-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  55 in total

1.  In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.

Authors:  N A Tatton; S J Kish
Journal:  Neuroscience       Date:  1997-04       Impact factor: 3.590

Review 2.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

3.  Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  A Rajeswari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2006 Jul-Aug       Impact factor: 3.507

4.  Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Authors:  A H Schapira; V M Mann; J M Cooper; D Dexter; S E Daniel; P Jenner; J B Clark; C D Marsden
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

5.  Walnuts lower serum cholesterol in Japanese men and women.

Authors:  M Iwamoto; M Sato; M Kono; Y Hirooka; K Sakai; A Takeshita; K Imaizumi
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

6.  Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice.

Authors:  Mani Kavitha; Jagatheesan Nataraj; Musthafa Mohammed Essa; Mushtaq A Memon; Thamilarasan Manivasagam
Journal:  Chem Biol Interact       Date:  2013-10-02       Impact factor: 5.192

7.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

Authors:  R E Heikkila; A Hess; R C Duvoisin
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

8.  Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer's disease.

Authors:  Lina Ji; Abha Chauhan; Jerzy Wegiel; Musthafa M Essa; Ved Chauhan
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

10.  Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut.

Authors:  W Elaine Hardman; Gabriela Ion
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

View more
  6 in total

1.  In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's Disease.

Authors:  Jin Gyu Choi; Gunhyuk Park; Hyo Geun Kim; Dal-Seok Oh; Hocheol Kim; Myung Sook Oh
Journal:  Int J Mol Sci       Date:  2016-01-15       Impact factor: 5.923

Review 2.  The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.

Authors:  Shanmugam Manoharan; Gilles J Guillemin; Rajagopal Selladurai Abiramasundari; Musthafa Mohamed Essa; Mohammed Akbar; Mohammed D Akbar
Journal:  Oxid Med Cell Longev       Date:  2016-12-27       Impact factor: 6.543

3.  Beneficial effects of date palm fruits on neurodegenerative diseases.

Authors:  Musthafa Mohamed Essa; Mohammed Akbar; Mohammed Abdul Sattar Khan
Journal:  Neural Regen Res       Date:  2016-07       Impact factor: 5.135

Review 4.  Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.

Authors:  Thirunavukkarasu Velusamy; Archana S Panneerselvam; Meera Purushottam; Muthuswamy Anusuyadevi; Pramod Kumar Pal; Sanjeev Jain; Musthafa Mohamed Essa; Gilles J Guillemin; Mahesh Kandasamy
Journal:  Oxid Med Cell Longev       Date:  2017-01-12       Impact factor: 6.543

Review 5.  A Comparative Review on the Extraction, Antioxidant Content and Antioxidant Potential of Different Parts of Walnut (Juglans regia L.) Fruit and Tree.

Authors:  Ali Jahanban-Esfahlan; Alireza Ostadrahimi; Mahnaz Tabibiazar; Ryszard Amarowicz
Journal:  Molecules       Date:  2019-06-05       Impact factor: 4.411

6.  Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells.

Authors:  Chinnasamy Dhanalakshmi; Thamilarasan Manivasagam; Jagatheesan Nataraj; Arokiasamy Justin Thenmozhi; Musthafa Mohamed Essa
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.